MASON, Ohio, January 25, 2024--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its fourth quarter and full year 2023 financial results on Thursday, February 15, 2024.
Related Keywords
Utah , United States , Ohio , Atricure Atriclip , Marissa Bych , Angie Wirick , Atricure Inc , Gilmartin Group , Nasdaq , Digital Health , Life Science , Diagnostic Tools Conference , Ablation System , Left Atrial Appendage Exclusion System , Atricure , Nc , Reatment Of Afib , Atrial Fibrillation , Audio Webcast ,
comparemela.com © 2020. All Rights Reserved.